HighTower Advisors, LLC

Position in FATE — Fate Therapeutics Inc

CIK 1462245 CHICAGO, IL

Back to FATE Full portfolio

Position in FATE

as of Jun 30, 2026 · filed Aug 5, 2026 Compact

Position Value

$90,325

+$47,939 QoQ

Shares Held

33,454

-5.3% QoQ

Ownership

0.028%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#76

of 156 holders

Holding Since

Mar 2021

22 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in FATE Over Time

Shares Held

Position Value (USD)

Derivatives in FATE

reported options exposure · as of Jun 30, 2021

CallValue

$1,000

CallShares

300

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

HighTower Advisors, LLC holds $312,855,129 across 115 Biotechnology names. FATE ranks #82 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INBX	Inhibrx Biosciences, Inc.	870,551	$82,484,707
2	REGN	Regeneron Pharmaceuticals, Inc.	64,650	$40,311,861
3	ALNY	Alnylam Pharmaceuticals, Inc.	105,045	$31,621,696
4	VRTX	Vertex Pharmaceuticals Inc / Ma	49,020	$24,349,704
5	RPRX	Royalty Pharma plc	285,630	$16,015,274
6	EXEL	Exelixis, Inc.	291,162	$15,842,124
7	AXSM	Axsome Therapeutics, Inc.	56,313	$13,783,733
8	ARWR	Arrowhead Pharmaceuticals, Inc.	140,394	$11,443,514

All Filings in FATE

Export CSV

24 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$90,325	33,454	-5.3%	Shares	Sole	2026-08-05
2026-03-31	$42,386	35,322	+9.6%	Shares	Sole	2026-05-05
2025-12-31	$31,574	32,219	-13.4%	Shares	Sole	2026-02-06
2025-09-30	$46,872	37,200	0.0%	Shares	Sole	2025-11-07
2025-06-30	$41,664	37,200	+264.7%	Shares	Sole	2025-08-11
2025-03-31	$8,058	10,200	0.0%	Shares	Sole	2025-05-13
2024-12-31	$16,830	10,200	-3.8%	Shares	Sole	2025-02-07
2024-09-30	$37,100	10,600	-5.4%	Shares	Sole	2024-11-14
2024-06-30	$36,749	11,204	+0.9%	Shares	Sole	2024-08-13
2024-03-31	$81,474	11,100	+1.8%	Shares	Sole	2024-05-06
2023-12-31	$40,766	10,900	-31.8%	Shares	Sole	2024-02-12
2023-09-30	$33,858	15,971	-1.2%	Shares	Sole	2023-11-08
2023-06-30	$76,973	16,171	-2.9%	Shares	Sole	2023-08-14
2023-03-31	$94,939	16,656	+5.6%	Shares	Sole	2023-05-12
2022-12-31	$159,169	15,775	-9.7%	Shares	Sole	2023-02-09
2022-09-30	$391,480	17,469	+67.2%	Shares	Sole	2022-11-09
2022-06-30	$258,951	10,450	-43.1%	Shares	Sole	2022-08-10
2022-03-31	$711,855	18,361	+5.9%	Shares	Sole	2022-05-12
2021-12-31	$1,014,855	17,345	+31.8%	Shares	Sole	2022-02-10
2021-09-30	$780,171	13,163	-3.6%	Shares	Sole	2021-11-12
2021-06-30	$1,184,683	13,650	+108.3%	Shares	Sole	2021-08-06
2021-06-30	$1,000	300	—	Call	Sole	2021-08-06
2021-03-31	$540,212	6,552	—	Shares	Sole	2021-05-10
2021-03-31	$82	1	—	Put	Sole	2021-05-10
No filing history on record for this holder in this stock.